Your session is about to expire
← Back to Search
Advanced Pneumatic Compression Device for Lymphedema
Study Summary
This trial is testing whether a new type of care for lymphedema and fibrosis (LEF) is better than the usual care for head and neck cancer (HNC) survivors.
- Lymphedema
- Facial Lymphedema
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Advanced Pneumatic Compression Device (APCD)
- Group 2: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the cohort size of this clinical experiment?
"To properly undertake this medical trial, Tactile Medical requires 250 suitable participants. To facilitate recruitment and treatment, Johns Hopkins University in Baltimore and Karmanos Cancer Institute in Detroit have both been selected as clinical sites."
Is the door open to new participants in this healthcare experiment?
"Affirmative. According to data hosted on clinicaltrials.gov, this medical experiment is actively recruiting individuals who meet the eligibility criteria. Initially posted on September 23rd 2021, it has most recently been updated on November 14th 2022 and requires 250 participants from 8 sites across the United States of America."
In how many different precincts is this research study being managed?
"Eight sites are currently enrolling participants in this study, including the Johns Hopkins University of Baltimore, Karmanos Cancer Institute of Detroit and Advanced Head & Neck Rehabilitation Center of Texas in Fort Worth. Additional locations exist as well."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger